Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin irritation / corrosion

Currently viewing:

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
06 Sep - 27 Nov 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Version / remarks:
28 July 2015
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
Version / remarks:
06 July 2012
Qualifier:
according to guideline
Guideline:
other: MatTek Corporation Protocol for: In Vitro EpiDermTM Skin Irritation Test (EPI-200-SCT) For use with MatTek Corporation’s Reconstructed Human Epidermal Model EpiDerm (EPI-200-SCT).
Version / remarks:
Version 07 -Nov- 2014
GLP compliance:
yes (incl. QA statement)
Remarks:
GLP-Landesleitstelle Bayer, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Germany

Test material

Constituent 1
Chemical structure
Reference substance name:
Bis(2-ethylhexyl) phosphonate
EC Number:
222-904-6
EC Name:
Bis(2-ethylhexyl) phosphonate
Cas Number:
3658-48-8
Molecular formula:
C16H35O3P
IUPAC Name:
bis(2-ethylhexyl) phosphonate
Test material form:
liquid

In vitro test system

Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Justification for test system used:
The test was carried out with the reconstituted three-dimensional human skin model EpiDermTM (MatTek). This skin model consists of normal (non-cancerous), human-derived epidermal keratinocytes (NHEK) which have been cultured to form a multilayered, highly differentiated model of the human epidermis. The NHEK are cultured on chemically modified, collagen-coated cell culture inserts (Millicell). The EpiDermTM skin model exhibits in vivo-like morphological and growth characteristics which are uniform and highly reproducible. It consists of organised basal, spinous, granular and cornified layers analogous to those found in vivo.
Vehicle:
unchanged (no vehicle)
Details on test system:
RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm (TM): reconstructed three-dimensional human epidermis model
- Tissue Lot number(s): 25840
- Date of initiation of testing: 06 Sep 2017

TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature
- Temperature of post-treatment incubation: 37 ± 1 °C

REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: the tissues were washed with DPBS to remove any residual test item; excess DPBS was removed by blotting the bottom with blotting paper.

MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg/mL
- Incubation time: 42 h at 37 ± 1 °C, 5.0% CO2
- Spectrophotometer: plate spectrophotometer
- Wavelength: 570 ± 30 nm

FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: MTT QC assay. 4 hours, n=3; the OD value (540 – 570 nm) locate in 1.0 – 3.0.
- Barrier function: ET-50 assay. 100 μL 1% Triton X- 100, 4 time – points. N=3, MTT assay; the ET-50 time locate in 4.77 - 8.72.

NUMBER OF REPLICATE TISSUES: 3 each, for the test substance, positive and negative control.

CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE: not applicable.

NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTI ON: single experiment.

PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant to skin if the tissue viability after 60 minutes exposure and 42 h post-incubation is less or equal to 50%.
- The test substance is considered to be non-irritant to skin if the viability after 60 minutes exposure and 42 h post-incubation is greater than 50%.
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount applied: 30 μL test item (undiluted) per tissue (47 μL/cm²)

NEGATIVE CONTROL
- Amount applied: 30 μL DPBS

POSITIVE CONTROL
- Amount applied: 30 μL SDS solution
- Concentration: 5%
Duration of treatment / exposure:
60 ± 1 min
Duration of post-treatment incubation (if applicable):
42 ± 4 h
Number of replicates:
3

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Remarks:
mean value of 3 tissues
Run / experiment:
60 ± 1 min
Value:
3
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of irritation
Other effects / acceptance of results:
- OTHER EFFECTS:
- Direct-MTT reduction: The mixture of 30 μL test item per 1 mL MTT medium showed no reduction of MTT compared to the solvent. The mixture did not turn blue/purple.
- Colour interference with MTT: The mixture of 30 μL test item per 300 μL aqua dest. and per 300 μL isopropanol showed no colouring detectable by unaided eye-assessment.

ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: the mean absolute OD570 of the three negative control tissues was >= 0.8 and <= 2.8.
- Acceptance criteria met for positive control: the mean relative tissue viability (% negative control) of the three positive control tissues was <= 20% (3.3 %).
- Acceptance criteria met for variability between replicate measurements: the standard deviation (SD) of viability of replicate tissues of all dose groups was <= 18% (0.4% - 4.3%).

Any other information on results incl. tables

Table 1. MTT assay after 60 min exposure

 Name        NK        PC        TM
 Tissue  1  2  3  1  2  3  1  2  3

Absolute OD570

2.378

2.329

2.488

2.472

2.632

2.491

0.147

0.155

0.105

0.107 

0.108

0.110 

0.124

0.120

0.105

0.106

0.120

0.121

OD570 (blank - corrected)

2.335

2.286

2.446

2.429

2.590

2.448

0.105

0.112

0.062

0.065

0.065

0.067

0.082

0.078

0.062

0.063

0.077

0.078

Mean OD570 of the duplicates (blank - corrected)

2.311 2.437  2.519 0.108  0.063 0.066 0.080 0.063 0.078

Total mean OD570 of 3 replicate tissues (blank - corrected)

2.422*    0.079

0.073

 SD OD570

0.105 0.025 0.009 

 Relative tissue viability [%]

95.4 100.6 104.0  4.5 2.6 2.7   3.3 2.6    3.2

 Mean relative tissue viability [%]

100.0 3.3** 3.0

 SD tissue viability [%]***

4.3 1.0 0.4

 CV [% viabilities]

4.3 31.7 12.4

* Blank-corrected mean OD570 nm of the negative control corresponds to 100% absolute tissue viability.

** Mean relative tissue viaability of the three positive control tissues is ≦ 20%.

*** Standard deviation (SD) obtained from the three concurrently tested tissues is ≦ 18%.

Applicant's summary and conclusion

Interpretation of results:
other: CLP/EU GHS Category 2 according to Regulation (EC) No 1272/2008
Conclusions:
CLP: Category 2
The test item showed irritant effects. The test item is therefore classified as "irritant" in accordance with CLP/EU GHS "Category 2".